Canada
Puerto Rico
USA
Belgium
France
UK
India
Overview
About the Session
Discover the exciting intersection of data and technology in the future of life sciences. Join our panel of leading experts as they examine the crucial role of Real-World Data (RWD) and Real-World Evidence (RWE). Gain valuable insights and practical applications into how AI and machine learning methodologies are used to leverage diverse data sources for clinical discoveries, improve patient care, and enhance regulatory decision-making.
- Learn about the latest trends, technologies, and methodologies transforming RWD and RWE
- Discuss future directions and challenges, including data privacy concerns, and emerging technologies
- Interact with panelists during the Q&A
Real-World Data and
Real-World Evidence in Life Sciences
Our Speakers
Ravi Iyer
Sr. Director, Head of RWE, Global HEVO Teva Pharmaceuticals
Arpita Nag
Global HEOR TA Head & Team Lead, AstraZeneca
Jeetvan Patel
Sr. Director, Franchise Head USHEOR & RWE - Radioligand Therapies, Novartis
Henry Levy
President, Life Sciences and Healthcare Clarivate
Lisa Arbogast
Industry Principal, Life Sciences Snowflake
Zhaohui Su
VP, Biostatistics, Ontada
Richard Gliklich, MD
CEO, OM1
Carl Marci, MD
Chief Clinical Officer, OM1
Gene Masin
Sr. Partner Solution Architect for Life Sciences, AWS
Doug Stover
Global Life Sciences BD, AWS
Ready to Innovate with Us?